Search Results
May 31, 2026, 08:00 ET GRAIL Presents PATHFINDER 2 Results of More Than 35,000 Participants Showing the Galleri® Test Substantially Increased Cancer Detection With Robust Performance and Favorable Safety at 2026 ASCO Annual Meeting
can meaningfully increase cancer detection beyond recommended screening with strong performance and a highly favorable safety profile. Along with the NHS-Galleri trial results, these findings reinforce the clinical benefit of Galleri and its potential to transform early cancer detection at population scale."Galleri
More news about: GRAIL, Inc.
May 30, 2026, 08:00 ET GRAIL Reports Full Results From NHS-Galleri Trial Demonstrating Substantial Reduction in Stage IV Cancer Diagnoses at 2026 ASCO Annual Meeting
Charles Swanton, thoracic medical oncologist at University College London Hospital, and one of the NHS-Galleri trial's chief investigators. "The NHS-Galleri trial tested whether adding the Galleri blood test to NHS screening could reduce the combined number of cancers diagnosed at Stage III or IV over three
More news about: GRAIL, Inc.
May 29, 2026, 17:48 ET NEUBERGER HIGH YIELD STRATEGIES FUND ANNOUNCES MONTHLY DISTRIBUTION
NEW YORK, May 29, 2026 /PRNewswire/ -- Neuberger High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stock. The distribution announced today is payable on May 29,
More news about: Neuberger Berman
May 29, 2026, 17:05 ET NEUBERGER HIGH YIELD STRATEGIES FUND ANNOUNCES MONTHLY DISTRIBUTION
NEW YORK, May 29, 2026 /PRNewswire/ -- Neuberger High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stock. The distribution announced today is payable on May 29,
More news about: Neuberger Berman
May 27, 2026, 10:05 ET Simpplr Gives IT Full Governance Over Intranet AI with New AI Control Center
enterprise-grade security and governance, Simpplr is designed to scale across complex organizations. More than 1,000 organizations — including AAA, the NHS, Penske, and Moderna — trust Simpplr to empower a connected, productive workforce. Learn more at
More news about: Simpplr
May 26, 2026, 13:56 ET The 'Hidden' Side Effect of Weight-Loss Drugs That Could Be Affecting Your Mouth, warns Oralieve
products like NEW Oralieve Soothing Lozenges into your daily routine can help!'And this growth is expected to accelerate over the coming years. NHS plans alone aim to expand access significantly, with hundreds of thousands of patients set to receive GLP-1 treatments in the near term
More news about: Oralieve UK
May 26, 2026, 08:45 ET New GCNC and Whitney Economics Report Examines Europe's Expanding Role in Global Cannabis Markets
market is expanding rapidly through private clinics and telemedicine, despite ongoing barriers tied to physician education, affordability, stigma and NHS participation.International cannabis trade into Europe continues accelerating, with imports flowing from Canada, Portugal, Latin America, Africa,
More news about: GCNC
May 26, 2026, 08:45 ET New GCNC and Whitney Economics Report Examines Europe's Expanding Role in Global Cannabis Markets
market is expanding rapidly through private clinics and telemedicine, despite ongoing barriers tied to physician education, affordability, stigma and NHS participation.International cannabis trade into Europe continues accelerating, with imports flowing from Canada, Portugal, Latin America, Africa,
More news about: GCNC
May 26, 2026, 07:30 ET Virax Biolabs Reports Positive Early Clinical Data for ViraxImmune™ in Long COVID and Related Post-Acute Infection Syndromes
the Lydia Becker Institute of Immunology and Inflammation, University of Manchester, and Consultant Respiratory Physician at Northern Care Alliance NHS Foundation Trust. "Objective immune profiling may help improve how these patients are assessed, stratified and monitored over time. These early pilot
More news about: Virax BioLabs Group Limited
May 25, 2026, 22:35 ET Хирургическая система Sentire® Surgical System получила маркировку CE Mark (MDR) -- Cornerstone Robotics вступает в новую эру своей глобальной экспансии
лечения пациентов по всему миру.До этого компания уже вышла на рынок Великобритании. С 2025 года CSR сотрудничает с Portsmouth Hospitals University NHS Trust (PHU) для проведения полностью соответствующего требуемым стандартам клинического исследования Sentire® Surgical System, постоянно накапливая реальные
More news about: Cornerstone Robotics
May 25, 2026, 22:30 ET Le système chirurgical Sentire® reçoit l'approbation du marquage CE (MDR), Cornerstone Robotics entre dans une nouvelle ère de son expansion mondiale
patients du monde entier.L'entreprise s'est rapidement implantée au Royaume-Uni. CSR collabore depuis 2025 avec Portsmouth Hospitals University NHS Trust (PHU) dans le cadre d'une étude clinique entièrement conforme du système chirurgical Sentire®, accumulant régulièrement des données cliniques réelles
More news about: Cornerstone Robotics
May 25, 2026, 22:28 ET Chirurgický systém Sentire® získava schválenie CE Mark (MDR) - Cornerstone Robotics vstupuje do novej éry globálnej expanzie
svete.Spoločnosť sa už pred časom udomácnila v Spojenom kráľovstve. Od roku 2025 spoločnosť CSR spolupracuje s Portsmouth Hospitals University NHS Trust (PHU) s cieľom vykonať plne kompatibilné klinické skúšanie chirurgického systému Sentire®. V rámci toho neustále zhromažďuje klinické údaje z reálneho
More news about: Cornerstone Robotics
May 25, 2026, 10:17 ET System chirurgiczny Sentire® otrzymał oznaczenie CE (MDR), a Cornerstone Robotics wkracza w nową erę globalnej ekspansji
całym świecie.Spółka wcześnie zaznaczyła swoją obecność w Wielkiej Brytanii. Od 2025 roku CSR współpracuje z Portsmouth Hospitals University NHS Trust (PHU) w celu przeprowadzenia w pełni zgodnego z przepisami badania klinicznego systemu chirurgicznego Sentire®, systematycznie gromadząc rzeczywiste
More news about: Cornerstone Robotics
May 25, 2026, 09:55 ET Das chirurgische System Sentire® erhält die CE-Kennzeichnung (MDR) und Cornerstone Robotics startet in eine neue Ära seiner globalen Expansion
zu versorgen.Das Unternehmen war schon früh im Vereinigten Königreich präsent. Seit 2025 arbeitet CSR mit dem Portsmouth Hospitals University NHS Trust (PHU) zusammen, um eine vollständig konforme klinische Untersuchung des Sentire® Surgical System durchzuführen und kontinuierlich reale klinische
More news about: Cornerstone Robotics
May 25, 2026, 08:45 ET A single dose of Lilly's PCSK9 base editor, VERVE-102, reduced PCSK9 by up to 88% and LDL-C by up to 62%, with durable effects supporting its potential as a one-time treatment for hypercholesterolemia
novel approach to achieving substantial and durable LDL-C reduction with a one-time treatment," said Riyaz S. Patel, M.D., cardiologist at Barts Health NHS Trust and professor of cardiology at University College London. "Many patients with elevated LDL-C struggle to achieve sustained control despite ongoing
More news about: Eli Lilly and Company
May 25, 2026, 04:32 ET El sistema quirúrgico Sentire® recibe la aprobación de la marca CE (MDR)
en todo el mundo.La empresa se estableció tempranamente en Reino Unido. Desde 2025, CSR se ha asociado con el Portsmouth Hospitals University NHS Trust (PHU) para llevar a cabo una investigación clínica del sistema quirúrgico Sentire® que cumple con todas las normativas, acumulando progresivamente
More news about: Cornerstone Robotics
May 25, 2026, 01:52 ET Sentire® Surgical System Receives CE Mark (MDR) Approval, Cornerstone Robotics Enters a New Era in its Global Expansion
and patients worldwide.The Company established an early presence in the UK. Since 2025, CSR has partnered with Portsmouth Hospitals University NHS Trust (PHU) to undertake a fully compliant clinical investigation of the Sentire® Surgical System, steadily accumulating real-world clinical data to
More news about: Cornerstone Robotics
May 20, 2026, 11:52 ET Global Alzheimer's Therapeutics Market Expands at 9.3% CAGR as Biologics and Early Diagnosis Transform Dementia Care
expansionGermany is strengthening early-stage diagnostic infrastructure and reimbursement frameworksThe United Kingdom is leveraging NHS-backed clinical research ecosystems and real-world evidence generationCountries such as Japan, India, the USA, Germany, and the UK are driving
More news about: Future Market Insights
May 20, 2026, 08:00 ET Corti launches Symphony for Speech-to-Text
practice management systems, and life sciences organisations worldwide. Corti serves over 100 million patients annually across health systems including the NHS. The company is headquartered in Copenhagen with offices in New York and London. For more information, visit corti.ai.Media contact
More news about: Corti
May 20, 2026, 08:00 ET Corti launches Symphony for Speech-to-Text
practice management systems, and life sciences organisations worldwide. Corti serves over 100 million patients annually across health systems including the NHS. The company is headquartered in Copenhagen with offices in New York and London. For more information, visit corti.ai.Media contact
More news about: Corti
May 19, 2026, 14:51 ET Altesa BioSciences Presents Positive Phase 2 Challenge Study Results for Vapendavir at American Thoracic Society International Conference 2026
by oscillometryNo safety or tolerability issues identifiedThe study was carried out at VirTus and Imperial College Healthcare NHS Trust using the only COPD rhinovirus challenge model in operation globally – a model designed to reproduce the upper and lower airway symptoms characteristic
More news about: Altesa Biosciences Inc.
May 19, 2026, 11:30 ET Portable Ultrasound Scanner Market Size to Hit USD 4.1 Billion, by 2032 at 5.7% CAGR: Allied Market Research
April 2025 - GE HealthCare Wins NHS England Multi-Year Agreement for Portable Ultrasound Deployment: GE HealthCare won a landmark multi-year institutional supply agreement with NHS England to deliver portable ultrasound devices for use across NHS hospitals and community health settings across
More news about: Allied Market Research
May 19, 2026, 09:35 ET Open Medicine Launches Ahead of ASCO, Introducing "Living Algorithms" for Real-Time Oncology Decision-Making
challenge is understanding how to use that data to benefit more patients," said Professor James Larkin, Consultant Medical Oncologist at The Royal Marsden NHS Foundation Trust "Living Algorithms make that more accessible by showing how experienced physicians actually assess patients and use therapies. They
More news about: Open Medicine
May 19, 2026, 08:00 ET Automation Anywhere Unveils 2026 Platform Enhancements to Run AI-Driven Processes Across the Enterprise
retail, telecommunications, and the public sector to run enterprise automation and AI-driven operations at scale.University Hospitals of Leicester NHS Trust, part of the United Kingdom's National Health Service and one of England's largest hospital groups, is using Agentic Process Automation to redesign
More news about: Automation Anywhere
May 19, 2026, 04:00 ET Queen Mary University of London and MCatalysis Awarded EPSRC and Defra Grant to Revolutionize Medical Waste Upcycling
economic and environmental benefit for the UK."The project comprises a prestigious consortium led by QMUL in collaboration with Barts Health NHS Trust, Cardiff University, and Imperial College London. The R&D will be driven out of Prof. Jie's labs at QMUL in close collaboration with MCatalysis.
More news about: MCatalysis, Inc.